Agency for Care Effectiveness - ACE

Agency for Care Effectiveness - ACE ACE is the national health technology assessment (HTA) and clinical guidance agency in Singapore. What We Do


I. II. III. IV.

Welcome to the official page of the Agency for Care Effectiveness (ACE). Established by the Ministry of Health, the Agency for Care Effectiveness (ACE) is the national Health Technology Assessment (HTA) and Clinical Guidance Agency in Singapore. We support providers, patients, and payers make better-informed decisions about patient care. We achieve this by conducting health technology assessments (HTAs), publishing healthcare guidances and providing education. HTA

Established by the Ministry of Health in 2015, we are the national HTA agency in Singapore. We conduct technical evaluations that inform funding decisions for health technologies, and drive their appropriate use by:

• Publishing technology guidances on the clinical effectiveness, safety, and cost-effectiveness of health technologies;
• Conducting value-based pricing negotiations with manufacturers to ensure that prices of patented health technologies are commensurate with the outcomes they deliver for patients and the Singapore health system;
• Tracking utilisation and outcomes related to funded health technologies to study the impact of funding decisions;
• Developing and implementing adoption strategies within public healthcare institutions to drive uptake of technology guidances. Clinical Guidance

We develop and publish clinical guidances that provide concise, evidence-based recommendations to inform specific areas of clinical practice. Healthcare Professional Education

We assist healthcare professionals to apply the best available evidence in their practice through collaborative continuing professional education. Healthcare Consumer Education

We provide information and tools for patients and caregivers to help them find out more about different medical conditions and treatment options, and to take part in shared decision-making with their clinicians about their healthcare needs. Find out more about our work at https://www.ace-hta.gov.sg/campaign/

-

Social Media Terms of Use

We encourage all visitors on our page to start conversations and share with us your thoughts, suggestions, and comments, if any. While we welcome constructive discussions, and want everyone’s experience to be positive, please note that any offensive posts or comments will be removed, and users that repeatedly breach the terms of use may also be blocked from this page. As social media is not a platform for clinical advice – please get in touch with your pharmacist or doctor regarding medical queries. Out of respect for users of our page, ACE reserves the right to remove any comments or posts of the following nature:
- Abusive, vulgar, obscene, violent or defamatory language
- Hateful or discriminatory remarks towards any specific groups or individuals
- Advertising, promotion or endorsement of any products, services or brands
- Fraudulent, inaccurate, non-evidence based information, including spam
- Violation of any copyright, contains proprietary or personal information (email addresses, phone numbers, account numbers etc.)
- Any other comments or posts that breach Facebook’s Term of Service of Community Standards.

17/02/2026

🍊 This Lunar New Year, we welcome the Year of the Horse — a symbol of strength, perseverance, and progress. As we come together to celebrate unity and resilience, we look forward to a year driven by renewed energy, hope, and shared purpose.

From all of us at ACE, we wish everyone a joyous Lunar New Year.

11/02/2026

We're excited to publish a new addition to our Voices to Impact flipbook! 📖

Our latest feature showcases how members of local patient groups partnered with ACE to co-develop factsheets on treatments for type 2 diabetes, turning medical jargon into accessible information and actionable steps.

Hear from Tiwari and Pratibha as they share their experience with the co-development process.

Click the link to read the full story: go.gov.sg/ace-voices-to-impact

23/01/2026

Immunotherapy is one of the treatment options for advanced non-small cell lung cancer (NSCLC) and several immunotherapy drugs are subsidised in Singapore for this condition.

Learn more about immunotherapy drugs for advanced NSCLC in our latest factsheet: go.gov.sg/acefb295

19/01/2026

ACE conducts technical evaluations to assess the effectiveness, safety, and value of health technologies (such as drugs, vaccines, and medical devices) to inform the Ministry of Health (MOH) advisory committees when they make funding recommendations. From October 2025 to the end of January 2026, patients, carers, and representatives from patient or voluntary organisations can submit applications to suggest which health technologies ACE should evaluate for funding. Topic suggestions close at the end of the month!

Read our factsheet to learn more about how patients can be involved and contact your patient organisation for an application form. go.gov.sg/aceli406

08/01/2026

Many people with chronic coronary heart disease (also known as chronic coronary syndrome) take antiplatelet medicines, such as aspirin, clopidogrel, or ticagrelor, to lower their risk of a heart attack.
Learn the common myths and facts about antiplatelet medicines in our patient education aid: go.gov.sg/acefb293

Singapore Heart Foundation

05/01/2026

We're excited to share a new addition to our Voices to Impact flipbook!

In this latest story, participants from six jurisdictions across the Asia-Pacific region, who attended the 12th HTAsiaLink 2025 Pre-Conference Patient Workshop, share their insights. The workshop was co-hosted by ACE and the Health Technology Assessment International (HTAi) Patient and Citizen Involvement in HTA Interest Group (PCIG).

Hear directly from the participants as they discuss:
• The impact of patient involvement in HTA
• Key enablers driving meaningful engagement
• Barriers to address in order to move forward

Click the link to read the full story on how the Asia-Pacific region is advancing patient-centred HTA decision-making: go.gov.sg/ace-voices-to-impact

✨ As we welcome 2026, we look forward to new opportunities to advance Appropriate and Value-Driven Care for patients, fa...
01/01/2026

✨ As we welcome 2026, we look forward to new opportunities to advance Appropriate and Value-Driven Care for patients, families and the healthcare system.

From all of us at ACE, thank you for your continued trust and partnership. May the year ahead bring you health, happiness and meaningful progress.

30/12/2025

ACE is excited to share our latest Consumer Engagement and Education (CEE) Updates!

Highlights include:
🌟 New stories in our Voices to Impact flipbook, featuring insights from the 12th HTAsiaLink 2025 Pre-Conference Patient Workshop on patient involvement in HTA across the Asia Pacific. We also include reflections from local patient groups who co-developed factsheets with ACE on treatments for type 2 diabetes.
📚 New factsheets to help patients make shared decision with their doctors about their healthcare needs.
📚 New plain English summaries explaining funding recommendations for health technologies, written in accessible language for patients and carers.
📢 Annual call for topics is still open until January 2026, inviting patients, carers, and patient organisations to suggest health technologies they would like ACE to evaluate.

Thank you to all patient organisations and the ACE Consumer Panel for your strong support this year. We look forward to continuing meaningful collaborations in 2026. Wishing everyone a joyful holiday season and a fulfilling new year ahead!

Read more in our latest CEE Updates: go.gov.sg/acefb292

🎄 As the year draws to a close, we pause to reflect on the partnerships, dedication and resilience that have carried us ...
25/12/2025

🎄 As the year draws to a close, we pause to reflect on the partnerships, dedication and resilience that have carried us through.

From all of us at ACE, we wish you and your loved ones a Christmas filled with joy, peace and good health — and a season of rest and renewal for the year ahead.

03/12/2025

Many people with chronic coronary heart disease (also known as chronic coronary syndrome) take antiplatelet medicines such as aspirin, clopidogrel, or ticagrelor, to lower their risk of a heart attack.

Learn the common myths and facts about antiplatelet medicines in
our patient education aid: https://go.gov.sg/acefb290

Singapore Heart Foundation

Address

College Of Medicine Building, 16 College Road
Singapore
169854

Alerts

Be the first to know and let us send you an email when Agency for Care Effectiveness - ACE posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Agency for Care Effectiveness - ACE:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram